Vorinostat
| CAS No. | 149647-78-9 |
|---|---|
| MDL No. | MFCD00945317 |
| MF | C14H20N2O3 |
| MW | 264.32 |
| InChI Key | WAEXFXRVDQXREF-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Vorinostat is a dicarboxylic acid diamide formed by coupling suberic (octanedioic) acid with aniline and hydroxylamine. It is a histone deacetylase inhibitor marketed as Zolinza for the treatment of cutaneous T cell lymphoma (CTCL). It functions as an EC 3.5.1.98 inhibitor, apoptosis inducer, and antineoplastic agent. It is also a hydroxamic acid and is functionally related to suberic acid, hydroxylamine, and aniline.
| CAS No. | 149647-78-9 |
|---|---|
| Product Name | Vorinostat |
Biological Targets
HDAC1·HDAC2·HDAC3·HDAC6
Associated Conditions
cancer·sarcoma·Cutaneous T-cell lymphoma·neoplasm of mature B-cells·MALT lymphoma·
* The information provided here is compiled from public sources and is for reference only.
